A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

ClinicalTrials.gov ID: NCT04965675

Public ClinicalTrials.gov record NCT04965675. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of IV Eptinezumab in Adolescents (12-17 Years) for the Preventive Treatment of Chronic Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.

Study identification

NCT ID: NCT04965675
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: H. Lundbeck A/S; Industry
Enrollment: 285 participants

Conditions and interventions

Conditions

Chronic Migraine in Children

Interventions

Eptinezumab Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 12 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 30, 2021 (Actual)
Primary completion: Mar 26, 2027 (Estimated)
Completion: Mar 26, 2027 (Estimated)
Last update posted: Oct 16, 2026

2021 – 2027

United States locations

U.S. sites: 22
U.S. states: 15
U.S. cities: 22

Facility	City	State	ZIP	Site status
Yale-New Haven Children's Hospital	New Haven	Connecticut	06504-8901	Completed
New England Institute for Clinical Research (NEICR) - Stamford	Stamford	Connecticut	06905-1206	Recruiting
Children's National Hospital - Children's National Heart Center	Washington D.C.	District of Columbia	20010-2916	Completed
Sarkis Clinical Trials - Gainsville	Gainesville	Florida	32607	Completed
NW FL Clinical Research Group, LLC	Gulf Breeze	Florida	32561-4495	Recruiting
AGA Clinical Trials	Hialeah	Florida	33012-3407	Recruiting
Axcess Medical Research - Loxahatchee	Loxahatchee Groves	Florida	33470-9206	Completed
University of South Florida (USF) - Tampa Campus	Tampa	Florida	33620	Recruiting
Clinical Integrative Research Center of Atlanta (CIRCAtl)	Atlanta	Georgia	30328-5574	Completed
UK HealthCare-Kentucky Clinic	Lexington	Kentucky	40536	Recruiting
University of Maryland-Marlene and Stewart Greenebaum Cancer Center	Baltimore	Maryland	21201-1595	Completed
Michigan Headache & Neurological Institute (MHNI)	Ann Arbor	Michigan	48104-5131	Completed
Corewell Health - Butterworth Hospital	Grand Rapids	Michigan	49503-2560	Completed
Dent Neurosciences Research Center	Amherst	New York	14226-1727	Completed
True North Neurology - Commack (North Suffolk Neurology)	Commack	New York	11725-2850	Completed
OnSite Clinical Solutions, LLC - Charlotte	Charlotte	North Carolina	28210-0106	Completed
Cincinnati Children's Hospital Medical Center-Burnet Campus	Cincinnati	Ohio	45229-3026	Recruiting
University of Oklahoma Health Sciences Center (OUHSC) - Stephenson Oklahoma Cancer Center	Oklahoma City	Oklahoma	73104-5418	Completed
Road Runner Research (RRR)	San Antonio	Texas	78249-3539	Recruiting
Children's Specialty Group (CSG)	Norfolk	Virginia	23510-1021	Recruiting
MultiCare Mary Bridge Children's Hospital and Health Center	Tacoma	Washington	98405-4234	Completed
Marshall Health-Marshall University Medical Center	Huntington	West Virginia	25701-3656	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04965675, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 16, 2026 · Synced Oct 20, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04965675 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →